Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Type of study
Language
Year range
1.
Indian J Ophthalmol ; 2016 May; 64(5): 405-406
Article in English | IMSEAR | ID: sea-179289
4.
Indian J Ophthalmol ; 2016 Jan; 64(1): 100-101
Article in English | IMSEAR | ID: sea-179093
5.
Arq. bras. oftalmol ; 78(4): 257-259, July-Aug. 2015. ilus
Article in English | LILACS | ID: lil-759264

ABSTRACT

ABSTRACTA 28-year-old man presented with bilateral vision loss. His best-corrected visual acuity (BCVA) was 0.3 in the right eye (OD) and 0.6 in the left eye (OS). Fundoscopy and fluorescein angiography showed angioid streaks encircling the optic discs of both eyes (OU). Spectral Domain Optical Coherence Tomography (SD-OCT) showed bilateral macular serous detachment. Systemic and ocular screening tests showed no specific cause for the angioid streaks. The patient had previously received pegaptanib sodium injection on three occasions, photodynamic therapy in OS, and no treatment in OD. Upon intravitreal injection of ranibizumab (twice in OU), subretinal fluid was nearly eliminated in OU. BCVA increased to 0.6 in OD and 0.9 in OS, and remained improved until 6 months after treatment.


RESUMOUm homem de 28 anos apresentou-se com perda de visão bilateral. A melhor acuidade visual corrigida (BCVA) era 0,3 no olho direito (OD) e 0,6 no olho esquerdo (OS). A fundoscopia e a angiofluoresceinografia demonstraram estrias angióides ao redor dos discos ópticos em ambos os olhos (OU). A tomografia de coerência óptica de domínio espectral (SD-OCT) demonstrou descolamento seroso macular bilateral. Testes de triagem sistêmicas e oculares não mostraram causa específica para estrias angióides. O paciente tinha um historia de três tratamentos com injeção de pegaptanibe sódico e terapia fotodinâmica em OS e nenhum tratamento em OD. Após a injeção intravítrea de ranibizumabe (duas vezes em OU), fluido sub-retiniano quase desapareceu em OU. BCVA melhorou para 0,6 em OD e 0,9 em OS e não se alterou até o sexto mês de tratamento.


Subject(s)
Adult , Humans , Male , Angiogenesis Inhibitors/therapeutic use , Angioid Streaks/drug therapy , Antibodies, Monoclonal/administration & dosage , Choroidal Neovascularization/drug therapy , Ranibizumab/therapeutic use , Antibodies, Monoclonal, Humanized , Angioid Streaks/complications , Bevacizumab/therapeutic use , Choroidal Neovascularization/etiology , Fluorescein Angiography , Intravitreal Injections , Tomography, Optical Coherence , Visual Acuity
6.
Indian J Ophthalmol ; 2014 Dec ; 62 (12): 1156-1158
Article in English | IMSEAR | ID: sea-155821

ABSTRACT

A 20‑year‑old man applied with vision loss in the left eye. Right eye examination was unremarkable. Best‑corrected visual acuity (BCVA) in the left eye was 20/200. Fundus examination revealed a few yellow spots within a round‑shaped macular lesion. Autofluorescence imaging showed hyperautofluorescence in the lesion. Central amplitudes in multifocal electroretinogram (mfERG) were depressed. The patient reported a rhinopharyngitis 7–10 days before the visual loss. The patient was diagnosed as acute retinal pigment epithelitis. BCVA improved gradually up to 20/20 in 4 weeks. mfERG amplitudes returned to normal. A slight pigmentary distortion was the only residual fundus finding.

SELECTION OF CITATIONS
SEARCH DETAIL